Jakub Závada

Institute of Rheumatology

Czech Republic

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (16)

Anne Gitte Loft

Aarhus University

DENMARK

View details

Lenka Hasikova

CZECH REPUBLIC

View details

Lucie Nekvindová

Institute of Biostatistics and Analyses, Ltd.

CZECH REPUBLIC

View details

Gareth Jones

University of Aberdeen

UNITED KINGDOM

View details

Tore Kristian Kvien

Professor

University of Oslo

NORWAY

View details

Tappei Takada

Associate Professor

JAPAN

View details

Jiri Vencovsky

Institute of Rheumatology

CZECH REPUBLIC

View details

Anna-Mari Hokkanen

Helsinki University Hospital

FINLAND

View details

Pavel Jesina

Gunma University Hospital

CZECH REPUBLIC

View details

Daniela Di Giuseppe

Karolinska University Hospital

SWEDEN

View details

Blanka Stiburkova

Institute of Rheumatology

CZECH REPUBLIC

View details

Pavel Horák

Fakultní Nemocnice Olomouc

CZECH REPUBLIC

View details

Michal Svoboda

Institute of Biostatistics and Analyses, Ltd.

CZECH REPUBLIC

View details

Anabela Barcelos

Centro Hospitalar do Baixo Vouga EPE

PORTUGAL

View details

David Friedecký

CZECH REPUBLIC

View details

Adéla Navrátilová

Institute of Rheumatology

CZECH REPUBLIC

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jakub Závada

Research Interests

Contact this professor

Articles (10)

Identification of pathogenic variants in the ABCG2 gene in patients with severe familial hyperuricemia and gout

Cut-Offs for Disease Activity States in Axial Spondyloarthritis With Ankylosing Spondylitis Disease Activity Score (ASDAS) Based on C-Reactive Protein and ASDAS Based on Erythrocyte Sedimentation Rate: Are They Interchangeable?

Drug survival analysis of etanercept compared with monoclonal antibody tumour necrosis factor-α inhibitors in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a propensity score-matched analysis from the Czech ATTRA registry

Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe

Alterations in lipidome profiles distinguish early-onset hyperuricemia, gout, and the effect of urate-lowering treatment

European bio-naïve spondyloarthritis patients initiating TNF inhibitor

Time in remission as an alternative outcome measure for rheumatoid arthritis: a 10-year prospective study of 2618 new users of anti-TNF

Switching first-line targeted therapy after not reaching low disease activity within 6 months is superior to conservative approach: a propensity score-matched analysis from the ATTRA registry

Patients with REM sleep behavior disorder have higher serum levels of allantoin.

IL-40: A New B Cell-Associated Cytokine Up-Regulated in Rheumatoid Arthritis Decreases Following the Rituximab Therapy and Correlates With Disease Activity, Autoantibodies, and NETosis.

Collaborators (16)

Anne Gitte Loft

Lenka Hasikova

Lucie Nekvindová

Gareth Jones

Tore Kristian Kvien

Tappei Takada

Jiri Vencovsky

Anna-Mari Hokkanen

Pavel Jesina

Daniela Di Giuseppe

Blanka Stiburkova

Pavel Horák

Michal Svoboda

Anabela Barcelos

David Friedecký

Adéla Navrátilová

Make your next move.